Investor's Business Daily on MSN
IBD stock of the day Medpace tests early buy point as biotech funding shines
Medpace Holdings is Tuesday's IBD Stock Of The Day. Shares are testing an early entry as the biotech funding environment ...
The biotech stocks get a lot of attention, from both stock analysts and investors, but the companies don’t exist in a vacuum. We are all familiar with their famously high overhead, but we might be ...
Revealing a significant insider sell on December 5, Mulford James Oliver III, CRO at TSS (NASDAQ:TSSI), as per the latest SEC filing. What Happened: III's decision to sell 55,772 shares of TSS was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results